Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Andrew J ArmstrongRavit GevaHyun Cheol ChungCharlotte LemechWilson H MillerAaron R HansenJong-Seok LeeFrank TsaiBenjamin J SolomonTae Min KimChristian RolfoVincent GirandaYixin RenFang LiuBhargava KandalaTomoko FreshwaterJudy S WangPublished in: Investigational new drugs (2024)